Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001823
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
1999-11-03
Brief Title:
Evaluation for NCI Surgery Branch Clinical Research Protocols
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Evaluation for NCI Surgery Branch Clinical Research Protocols
Status:
RECRUITING
Status Verified Date:
2024-09-26
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background
The National Cancer Institute Surgery Branch NCI-SB has developed experimental therapies that involve taking white blood cells from patients tumor or from their blood growing them in the laboratory in large numbers and then giving the cells back to the patient
Objective
This study will allow patients to under screening and evaluation for participation in NC-SB Protocols
Eligibility
Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol
Design
Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol
The National Cancer Institute Surgery Branch NCI-SB has developed experimental therapies that involve taking white blood cells from patients tumor or from their blood growing them in the laboratory in large numbers and then giving the cells back to the patient
Objective
This study will allow patients to under screening and evaluation for participation in NC-SB Protocols
Eligibility
Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol
Design
Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol
Detailed Description:
Background
Potential research candidates undergo thorough screening including laboratory tests scans x-rays and review of pathology slides to determine initial eligibility for National Cancer Institute Surgery Branch NCI-SB research protocols
Objectives
Permit evaluation of patients referred to the NCI-SB in order to identify individuals who will be suitable candidates for NCI-SB clinical research protocols
To assess frequency of HLA type gene specific mutations or expression of neo antigens in malignant tumors across the population of cancer patients undergoing screening for NCI-SB protocols
Collect results of screening tests for use on subsequent research protocol as baseline eg pretreatment values
Eligibility
Age 18 years
Patient suspected of having or with biopsy proven malignant disease
Patient is able to understand and willing to sign a written informed consent document
Patient is being evaluated for treatment on an NCI-SB protocols
Design
Patients enrolled on this protocol will be evaluated by NCI-SB physicians to determine the individuals suitability for participation in a clinical research protocol An accrual ceiling of 7000 patients has been set to meet the screening needs of the NCI-SB
Potential research candidates undergo thorough screening including laboratory tests scans x-rays and review of pathology slides to determine initial eligibility for National Cancer Institute Surgery Branch NCI-SB research protocols
Objectives
Permit evaluation of patients referred to the NCI-SB in order to identify individuals who will be suitable candidates for NCI-SB clinical research protocols
To assess frequency of HLA type gene specific mutations or expression of neo antigens in malignant tumors across the population of cancer patients undergoing screening for NCI-SB protocols
Collect results of screening tests for use on subsequent research protocol as baseline eg pretreatment values
Eligibility
Age 18 years
Patient suspected of having or with biopsy proven malignant disease
Patient is able to understand and willing to sign a written informed consent document
Patient is being evaluated for treatment on an NCI-SB protocols
Design
Patients enrolled on this protocol will be evaluated by NCI-SB physicians to determine the individuals suitability for participation in a clinical research protocol An accrual ceiling of 7000 patients has been set to meet the screening needs of the NCI-SB
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 99-C-0128 | None | None | None |